Peritumoral administration of GPI-anchored TIMP-1 inhibits colon carcinoma growth in Rag-2 gamma chain-deficient mice (Q39832672)

15 September 2017

title

Peritumoral administration of GPI-anchored TIMP-1 inhibits colon carcinoma growth in Rag-2 gamma chain-deficient mice (English)

1 reference

15 September 2017

1 reference

Matthias C Raggi

1

1 reference

15 September 2017

Roghieh Djafarzadeh

2

1 reference

15 September 2017

Niklas Muenchmeier

3

1 reference

15 September 2017

Monika Hofstetter

4

1 reference

15 September 2017

Birgit Jahn

5

1 reference

15 September 2017

Nicole Rieth

6

1 reference

15 September 2017

Peter J Nelson

7

1 reference

15 September 2017

publication date

1 September 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

390

1 reference

15 September 2017

issue

9

1 reference

15 September 2017

page(s)

893-897

1 reference

Novel functions of TIMPs in cell signaling

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.098

Exogenously added GPI-anchored tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) displays enhanced and novel biological activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.098

GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.098

Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.098

Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.098

Tumor progression: defining the soil round the tumor seed

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.098

Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.098

Structure and function of matrix metalloproteinases and TIMPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.098

Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.098

CD3 epsilon-mediated signals rescue the development of CD4+CD8+ thymocytes in RAG-2-/- mice in the absence of TCR beta chain expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.098

Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.098

Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FBC.2009.098

21 January 2018

Identifiers

DOI

10.1515/BC.2009.098

1 reference

15 September 2017

1 reference